Transforming procurement with AstraZeneca

Enabling rapid growth and innovation for the future

AstraZeneca was sitting on legacy Procure-to-Pay (P2P) technology that was no longer fit for its rapid growth and the breadth of goods and suppliers that it needed to manage. The pharmaceutical giant needed a trusted partner to transform it’s $9 billion procurement system across 11 countries, with 35,00 users and over 20,000 suppliers.

With this challenge in mind, we conducted a comprehensive assessment on how ready AstraZeneca was to embark on this change. It quickly became clear that delivering a step change in user experience was a key priority and Coupa’s leading Procure-to-Pay platform was selected to help enable this transformation.

Paul Desrosiers

Partner, Powered Procurement

KPMG in the UK

mail
call

Transforming procurement with AstraZeneca

Enabling rapid growth and innovation for the future

A core goal of the transformation programme was to align ways of working across functions and geographies into a single standardised model and way to buy. The key design principles we worked towards were:

User experience is paramount to the design
Supplier engagement and simplicity is a priority
Adopt not adapt - no customisation of best practice technology
A single standardised global core design
Enabling the value of world class procurement

Read our client story to find out how we future proofed the Procure-to-Pay process, built learning pathways for stakeholders and the benefits for end users, suppliers, finance, IT and procurement.